Fig. 2From: A systematic review and meta-analysis assessing antiretroviral therapy for treatment-experienced HIV adult patients using an optimized background therapy approach: is there evidence enough for a standardized third-line strategy?Meta-analysis comparing treatment and control groups. *Studies presenting data at week 24. Outcome: proportion of patients with < 200 HIV-1 RNA copies/mL. Outcome: proportion of patients with < 50 HIV-1 RNA copies/mL at week 48. Obs. BENCHMRK studies present data in a 96-week follow-upBack to article page